Elevated Capital Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Sell
639
-386
-38% -$169K 0.07% 228
2026
Q1
$473K Sell
1,025
-50
-5% -$25.3K 0.12% 187
2025
Q4
$609K Sell
1,075
-237
-18% -$126K 0.14% 175
2025
Q3
$587K Sell
1,312
-173
-12% -$83K 0.15% 181
2025
Q2
$735K Hold
1,485
0.21% 152
2025
Q1
$735K Sell
1,485
-108
-7% -$59.7K 0.21% 152
2024
Q4
$831K Sell
1,593
-103
-6% -$53.6K 0.23% 129
2024
Q3
$833K Sell
1,696
-4
-0.2% -$1.86K 0.22% 142
2024
Q2
$756K Buy
1,700
+144
+9% +$57.4K 0.21% 130
2024
Q1
$621K Buy
1,556
+42
+3% +$15.9K 0.18% 122
2023
Q4
$511K Buy
1,514
+124
+9% +$37K 0.16% 128
2023
Q3
$406K Sell
1,390
-16
-1% -$5K 0.14% 135
2023
Q2
$481K Buy
1,406
+81
+6% +$24.5K 0.16% 135
2023
Q1
$338K Buy
1,325
+55
+4% +$13.6K 0.12% 145
2022
Q4
$337K Buy
+1,270
New +$310K 0.13% 134

Other funds holding ISRG

Elevated Capital Advisors's ISRG Position: Q2 2026 in Review

Elevated Capital Advisors reduced its Intuitive Surgical (ISRG) stake by 38% in Q2 2026, selling an estimated $169K and leaving 639 shares worth $254K. The position accounts for 0.07% of the portfolio, ranked #228.

Elevated Capital Advisors first reported a position in ISRG in Q4 2022 and has held it in 15 quarters since. The position peaked at $833K in Q3 2024. 2,236 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Elevated Capital Advisors held 639 shares of Intuitive Surgical worth $254K as of Q2 2026.
  • Elevated Capital Advisors sold 386 Intuitive Surgical shares in Q2 2026, an estimated $169K.
  • Intuitive Surgical made up 0.07% of Elevated Capital Advisors's portfolio in Q2 2026, its #228 holding.
  • Elevated Capital Advisors first reported a position in Intuitive Surgical in Q4 2022 and has held it in 15 quarters since.
  • Elevated Capital Advisors's Intuitive Surgical position peaked at $833K in Q3 2024.
  • 2,236 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.